The Meals and Drug Administration first accredited the injectable medication for dealing with diabetes in 2017; the company authorized a drug with a higher dose from the Lively component in copyright, called semaglutide, to treat obesity in 2021, under the brand name Wegovy. Since then, speak of the drug has popped up throughout the web. Elon Musk,